Thin, dry, and aging skin is a complex condition driven by a combination of intrinsic factors, such as hormonal changes, and extrinsic stressors like environmental exposure. These factors lead to a decline in collagen synthesis and an increase in enzymatic degradation, resulting in a compromised skin barrier, loss of dermal density, and visible fragility. Traditional moisturizing approaches often only provide temporary surface-level hydration. To address the underlying molecular mechanisms, biomimetic peptides like Tripeptide-29 were considered a potential solution because they mimic native collagen sequences to signal fibroblasts to increase collagen production while limiting degradation. This study specifically evaluated a multi-mechanistic formulation that combines this peptide with synergistic actives—Niacinamide, Watermelon fruit extract, and Selaginella lepidophylla extract—to simultaneously target barrier strength, antioxidant protection, and cellular moisture retention.
Methods
In this prospective, single-center study, 47 healthy women aged 36–65 applied a multi-active serum lotion twice daily to their face and body over four weeks. Efficacy and safety were evaluated using standardized objective tools—including Antera 3D imaging, Corneometer, Vapometer, and Cutometer—alongside expert clinical grading and participant self-assessments. Measurements were collected at various intervals, from 15 minutes post-application to the end of the four-week period, to assess both immediate and cumulative skin benefits.
Key Findings
- Rapid and Sustained Hydration: Facial hydration improved by 72.5% immediately after application, with dryness decreasing by 93.7% by the end of week four.
- Enhanced Barrier Function: Significant reductions in trans-epidermal water loss (TEWL) indicated a strengthened skin barrier, and visible scaliness (desquamation) improved by 75.5% by week three.
- Wrinkle Reduction and Volumetric Gains: Objective 3D imaging revealed a 32.7% reduction in cheek wrinkles and a 30.8% increase in volume in the thigh/buttock region by week four.
- Improved Skin Texture and Elasticity: Clinical grading confirmed significant gains in skin softness (up to 37.7%) and smoothness (up to 37.9%), while instrumental assessments showed enhanced elastic recovery and resilience.
- High Tolerability and Consumer Satisfaction: The formulation was well-tolerated with no adverse effects, and over 90% of participants praised its lightweight, non-greasy, and rapidly absorbing sensory profile.
The novelty of this research lies in its successful integration of biomimetic Tripeptide-29 with a synergistic blend of actives in a dual-purpose face and body emulsion, bridging the gap between specialized facial anti-aging treatments and general body care. By addressing multiple pathophysiological mechanisms of aging simultaneously, the study proves that a single high-performance formulation can deliver clinical-grade results across diverse anatomical sites. Future implications suggest that this multi-mechanistic approach could redefine consumer adherence by simplifying routines without compromising efficacy. However, future randomized, placebo-controlled trials with larger and more diverse populations are necessary to further validate these findings and establish long-term cumulative benefits.
Link to the study: https://www.mdpi.com/2079-9284/13/2/64
A combined bar and line chart illustrating hydration improvement on the outer lower leg from immediate to 72 h post-application, with a strong initial effect (+50.9%; 100% of subjects improved; p < 0.0001).